GKB — AGM Information 2022

Jun 7, 2022

Grape King Bio Ltd

Meeting Notice of Annual Shareholders’ Meeting (Summary Translation)

The 2022 Annual Shareholders’ Meeting (the “Meeting”) of Grape King Bio Ltd (the “Company”) will convene at 9:00am on May 27, 2022 at Grape King Bio Headquarters, 8F No.402, Sec. 2, Jinling Rd., Pingzhen Dist., Taoyuan City, Taiwan. The meeting registration for Shareholders starts at 8:30am at the above mentioned Pingzhen address. Please be advised that Covid checks will be carried out in accordance with the Government Requirements.

• I. The agenda for the Meeting is as follows:

1. Reporting Items

• (1) 2021 Business Report

• (2) Audit committee’s Review Report on the 2021 Financial Statements

• (3) Report on Remuneration Distribution for Employees and Directors for the Year 2021.

1. Matters for Ratification

   • (1) Adoption of the 2021 Business Report and Financial Statements

   • (2) Adoption of the Proposal for Distribution of 2021 Profits

2. Matters for Discussion

   • (1) To amend the Company’s Articles of Incorporation

   • (2) To amend the Company’s Procedure for the Acquisition and Disposal of Assets

4. Extempore motion

II. If the Company decides to hold a meeting under Article 172 of the Company Law, electronic files will be posted to the Market Observation Post System at https://emops.twse.com.tw. Please select "Shareholders' Meetings" under the "Electronic Books" tab, enter the year, and click "GO" to find the meeting files corresponding to Company code.

III. The major items of the proposal for distribution of 2021 profits are as follows ：

The Company will distribute a cash dividend amounting to NT$903,637,975 which is obtained from retained earnings, valued at NT$6.1 per share, and estimated by rounding down to the dollar value. The fractional amount will be included in the Company’s other income. Upon approval during the Annual Meeting of Shareholders, it is proposed that the Board of Directors be authorized to resolve the ex-dividend date, ex-rights date, and other relevant issues.

• IV. Pursuant to Article 165 of the Company Act, the Company hereby closes the share transfer registration from March 29, 2022 to May 27, 2022.

• V. Please find enclosed the "Notice of Attendance" and "Proxy Statement." If you intend to personally attend the meeting, please sign or place your seal in the "Registration Card" column. Shareholders may sign or place their seal in the "Proxy Statement" column to appoint a proxy to attend the meeting on his or her behalf and execute power of attorney in writing. Please fill in the "Proxy Statement" and deliver to the Company's stock agency, Capital Securities Corporation. Transfer Agent, no later than May 20, 2022, 5 days prior to

• the meeting date.

• VI. The company will compile a summary statement of the relevant information provided by shareholders through solicitation of the proxy and disclose the content in the website of Securities & Futures Institute (SFI) on April 26, 2022. Shareholders can navigate to SFI's web page (https://free.sfi.org.tw) to view relevant information. (TWSE code:1707)

• VII. The Transfer Agency Department of Capital Securities Corporation is the proxy tallying and verification institution for this Annual meeting.

• VIII. Shareholders may exercise his/her/its voting rights by way of electronic transmission during the period from April 27, 2022 to May 24, 2022. Please log in the “Stockvote” (https://www.stockvote.com.tw) of Taiwan Depository & Clearing Corporation (TDCC) and vote in.

To Shareholders

***During COVID-19 epidemic period:

1. Shareholders are kindly requested and encouraged to use the e-vote system to exercise their voting rights.

2. Shareholders who attend the annual shareholders’ meeting must prepare and wear a facial mask for the full duration of the meeting. If any shareholders or attendees do not wear a facial mask, they will not be allowed to enter the building and meeting venue. Shareholders and attendees will also have their body temperature taken before being allowed entry to the building and meeting venue. If a Shareholder or attendee’s body temperature is equal to or exceeds forehead temperature measurement above 37.5 °C, and/or ear temperature measurement above 38 °C, they will not be allowed to enter the venue. A maximum of two temperature measurements will be taken for each individual. Shareholders are kindly requested to cooperate with Covid-19 and reminded that failure to comply with the above epidemic prevention measures. The Company reserves the right to refuse entry to the building and meeting venue.

3. If a change to the meeting venue is deemed necessary due to COVID-19, the Company will make the related public announcements on Market Observation Post System (MOPS). ***

(This translated document is prepared in accordance with the Chinese version and is for reference only. In the event of any inconsistency between the English version and the Chinese version, the Chinese version shall prevail.)